- Report
- May 2022
- 217 Pages
Asia Pacific
From €2605EUR$2,950USD£2,250GBP
- Report
- October 2021
- 70 Pages
United States
From €963EUR$1,090USD£831GBP
- Report
- October 2021
- 199 Pages
Global
From €4901EUR$5,550USD£4,233GBP
- Report
- April 2021
- 85 Pages
United States
From €1147EUR$1,299USD£991GBP
- Report
- January 2021
- 50 Pages
Global
€5000EUR$6,065USD£4,470GBP
- Report
- December 2020
- 200 Pages
Global
€3930EUR$4,450USD£3,394GBP
- Report
- August 2020
- 140 Pages
Global
€3990EUR$4,840USD£3,567GBP
- Report
- May 2018
- 106 Pages
Global
From €3091EUR$3,500USD£2,670GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
North America
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
Middle East
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
Asia Pacific
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United States
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United Kingdom
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United States
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
North America
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
Middle East
From €3523EUR$3,990USD£3,043GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more